Cargando…
Sarcopenia is poor risk for unfavorable short- and long-term outcomes in stage I non-small cell lung cancer
BACKGROUND: Sarcopenia characterized by skeletal muscle loss may influence postoperative outcomes through physical decline and weakened immunity. We aimed to investigate clinical significance of sarcopenia in resected early-stage non-small cell lung cancer (NSCLC). METHODS: We retrospectively review...
Autores principales: | Takahashi, Yusuke, Suzuki, Shigeki, Hamada, Kenichi, Nakada, Takeo, Oya, Yuko, Sakakura, Noriaki, Matsushita, Hirokazu, Kuroda, Hiroaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944314/ https://www.ncbi.nlm.nih.gov/pubmed/33708952 http://dx.doi.org/10.21037/atm-20-4380 |
Ejemplares similares
-
Clinical adjustability of radiological tools in patients with surgically resected cT1N0-staged non-small-cell lung cancer from the long-term survival evaluation
por: Kuroda, Hiroaki, et al.
Publicado: (2020) -
Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer with ALK Rearrangement
por: Oya, Yuko, et al.
Publicado: (2020) -
Survival benefit of immune checkpoint inhibitor monotherapy in patients with non-small cell lung cancer recurrence after completely pulmonary resection
por: Kuroda, Hiroaki, et al.
Publicado: (2021) -
An extended modification of transmanubrial osteomuscular sparing approach: salvage resection for recurrent superior sulcus lung cancer after definitive chemoradiotherapy
por: Sakakura, Noriaki, et al.
Publicado: (2021) -
Clinical Guideline-Guided Outcome Consistency for Surgically Resected Stage III Non-Small Cell Lung Cancer: A Retrospective Study
por: Kuroda, Hiroaki, et al.
Publicado: (2021)